
|Videos|November 6, 2020
The Ongoing Fight Against Acute GvHD
Author(s)John DiPersio, MD, PhD
A key opinion leader provides insight into recent data updates from ongoing trials studying the management of GvHD with promising regimens.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































